NCT02107144View on ClinicalTrials.gov

The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Coronary Artery DiseaseMicrocirculationVascular Resistance
Interventions
DRUG

trimetazidine

After being randomized to Trimetazidin and cardiac medication vs. only cardiac medication, patient will undergo scheduled PCI of single, new, native coronary artery lesion using balloon predilatation and subsequent stenting.

Trial Locations (1)

11040

Institute for cardiovascular diseases Dedinje, Belgrade

All Listed Sponsors
lead

Clinical Hospital Center Zemun

OTHER

NCT02107144 - The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery Disease | Biotech Hunter | Biotech Hunter